Abstract
DNA microarrays are widely used to study changes in gene expression in tumors, but such studies are typically system-specific and do not address the commonalities and variations between different types of tumor. Here we present an integrated analysis of 1,975 published microarrays spanning 22 tumor types. We describe expression profiles in different tumors in terms of the behavior of modules, sets of genes that act in concert to carry out a specific function. Using a simple unified analysis, we extract modules and characterize gene-expression profiles in tumors as a combination of activated and deactivated modules. Activation of some modules is specific to particular types of tumor; for example, a growth-inhibitory module is specifically repressed in acute lymphoblastic leukemias and may underlie the deregulated proliferation in these cancers. Other modules are shared across a diverse set of clinical conditions, suggestive of common tumor progression mechanisms. For example, the bone osteoblastic module spans a variety of tumor types and includes both secreted growth factors and their receptors. Our findings suggest that there is a single mechanism for both primary tumor proliferation and metastasis to bone. Our analysis presents multiple research directions for diagnostic, prognostic and therapeutic studies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Ramaswamy, S., Ross, K.N., Lander, E.S. & Golub, T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49–54 (2003).
Ramaswamy, S. et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. USA 98, 15149–15154 (2001).
Lamb, J. et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323–334 (2003).
Rhodes, D.R. et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. USA 101, 9309–9314 (2004).
Mootha, V.K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–723 (2003).
Su, A.I. et al. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. USA 99, 4465–4470 (2002).
Kanehisa, M., Goto, S., Kawashima, S. & Nakaya, A. The KEGG databases at GenomeNet. Nucleic Acids Res. 30, 42–46 (2002).
Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29 (2000).
Dahlquist, K.D., Salomonis, N., Vranizan, K., Lawlor, S.C. & Conklin, B.R. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet. 31, 19–20 (2002).
Kim, S.C. et al. Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1. Blood 93, 3893–3899 (1999).
Chu, Y., Solski, P.A., Khosravi-Far, R., Der, C.J. & Kelly, K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271, 6497–6501 (1996).
Furukawa, T., Sunamura, M., Motoi, F., Matsuno, S. & Horii, A. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am. J. Pathol. 162, 1807–1815 (2003).
Leone, A.M., Errico, M., Lin, S.L. & Cowen, D.S. Activation of extracellular signal-regulated kinase (ERK) and Akt by human serotonin 5-HT(1B) receptors in transfected BE(2)-C neuroblastoma cells is inhibited by RGS4. J. Neurochem. 75, 934–938 (2000).
Shi, C.S. et al. Regulator of G-protein signaling 3 (RGS3) inhibits Gbeta1gamma 2-induced inositol phosphate production, mitogen-activated protein kinase activation, and Akt activation. J. Biol. Chem. 276, 24293–24300 (2001).
Ge, B. et al. TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. J. Biol. Chem. 278, 2286–2293 (2003).
Mita, H., Tsutsui, J., Takekawa, M., Witten, E.A. & Saito, H. Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding. Mol. Cell. Biol. 22, 4544–4555 (2002).
Granata, O.M. et al. Altered androgen metabolism eventually leads hepatocellular carcinoma to an impaired hormone responsiveness. Mol. Cell. Endocrinol. 193, 51–58 (2002).
Mundy, G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2, 584–593 (2002).
Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537–459 (2003).
Iguchi, H. et al. A possible role of VEGF in osteolytic bone metastasis of hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 21, 309–313 (2002).
Boot, A.M., van den Heuvel-Eibrink, M.M., Hahlen, K., Krenning, E.P. & de Muinck Keizer-Schrama, S.M. Bone mineral density in children with acute lymphoblastic leukaemia. Eur. J. Cancer 35, 1693–1697 (1999).
Ugolini, F. et al. Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene 18, 1903–1910 (1999).
Reinholz, M.M., Iturria, S.J., Ingle, J.N. & Roche, P.C. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR. Breast Cancer Res. Treat. 74, 255–269 (2002).
Bernards, R. & Weinberg, R.A. A progression puzzle. Nature 418, 823 (2002).
Hynes, R.O. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell 113, 821–823 (2003).
Ferrari, N. et al. DLX genes as targets of ALL-1: DLX 2,3,4 down-regulation in t(4;11) acute lymphoblastic leukemias. J. Leukoc. Biol. 74, 302–305 (2003).
Segal, E. et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat. Genet. 34, 166–176 (2003).
Ihmels, J. et al. Revealing modular organization in the yeast transcriptional network. Nat. Genet. 31, 370–377 (2002).
Tanay, A., Sharan, R., Kupiec, M. & Shamir, R. Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data. Proc. Natl. Acad. Sci. USA 101, 2981–2986 (2004).
Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863–14868 (1998).
Acknowledgements
We thank J. Effrat, T. Fojo, Y. Friedman, A. Kaushal, W. Lu, T. Pham, M. Tong, and R. Yelensky for technical help with software and visualization and I. Ben-Porath, Y. Dor, L. Garwin, N. Kaminski, D. Pe'er, O. Rando and T. Raveh for comments on previous versions of this manuscript. E.S., N.F. and D.K. were supported by a National Science Foundation grant under the Information Technology Research program. E.S. was also supported by a Stanford Graduate Fellowship. N.F. was also supported by an Alon Fellowship, by the Harry & Abe Sherman Senior Lectureship in Computer Science and by the United States-Israel Bi-National Science Foundation grant. N.F. and A.R. were supported by a Center of Excellence Grant from the National Institute of General Medical Sciences. A.R. was also supported by the Bauer Center for Genomics Research.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Statistical significance of the procedure for deriving a module from a gene set cluster. (PDF 88 kb)
Supplementary Fig. 2
Distribution of the significant array-gene set pairs by conditions. (PDF 106 kb)
Supplementary Table 1
Microarray data sources for the cancer compendium. (PDF 34 kb)
Rights and permissions
About this article
Cite this article
Segal, E., Friedman, N., Koller, D. et al. A module map showing conditional activity of expression modules in cancer. Nat Genet 36, 1090–1098 (2004). https://doi.org/10.1038/ng1434
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1434